| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70518-2907-1 | 70518-2907 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | FENOFIBRATE | TABLET | ORAL | 20210113 | N/A | ANDA | ANDA213864 | REMEDYREPACK INC. | FENOFIBRATE | 160 mg/1 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2907-1) |
| 70756-215-51 | 70756-215 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | FENOFIBRATE | TABLET | ORAL | 20200910 | N/A | ANDA | ANDA213864 | Lifestar Pharma LLC | FENOFIBRATE | 160 mg/1 | 500 TABLET in 1 BOTTLE (70756-215-51) |
| 70756-215-90 | 70756-215 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | FENOFIBRATE | TABLET | ORAL | 20200910 | N/A | ANDA | ANDA213864 | Lifestar Pharma LLC | FENOFIBRATE | 160 mg/1 | 90 TABLET in 1 BOTTLE (70756-215-90) |
| 72603-841-01 | 72603-841 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | FENOFIBRATE | TABLET | ORAL | 20250929 | N/A | ANDA | ANDA213864 | NorthStar RxLLC | FENOFIBRATE | 160 mg/1 | 90 TABLET in 1 BOTTLE (72603-841-01) |
| 72603-841-02 | 72603-841 | HUMAN PRESCRIPTION DRUG | FENOFIBRATE | FENOFIBRATE | TABLET | ORAL | 20250929 | N/A | ANDA | ANDA213864 | NorthStar RxLLC | FENOFIBRATE | 160 mg/1 | 500 TABLET in 1 BOTTLE (72603-841-02) |